{
  "kind": "explainer",
  "discoverable": true,
  "related": [
    {
      "slug": "vaccines-autism",
      "label": "Vaccines don't cause autism",
      "reason": "Read the outcome-specific evidence."
    },
    {
      "slug": "vaccine-schedule",
      "label": "Childhood schedules",
      "reason": "Antigen exposure and spacing are different questions."
    },
    {
      "slug": "covid-cancer-dna",
      "label": "COVID vaccines and DNA",
      "reason": "Understand residual manufacturing DNA."
    }
  ],
  "id": "vaccine-ingredients-safety",
  "slug": "vaccine-ingredients",
  "title": "Vaccine ingredients have a strong safety record",
  "summary": "Vaccine ingredients have specific jobs, such as strengthening protection or keeping the vaccine stable. Safety depends on the amount, chemical form and how it enters the body. Studies support the safety of the amounts used. Serious reactions are rare.",
  "keyPoints": [
    {
      "text": "Dose, chemical form and route matter when assessing an ingredient.",
      "sources": [
        1,
        7
      ]
    },
    {
      "text": "The ingredient list is specific to each vaccine.",
      "sources": [
        2,
        3
      ]
    },
    {
      "text": "Aluminum and thimerosal have not been shown to cause autism.",
      "sources": [
        9
      ]
    }
  ],
  "evidence": [
    {
      "id": "ingredient-purpose",
      "heading": "Each ingredient has a job",
      "text": "Some ingredients train the immune response; others help it work, keep a vaccine stable or prevent contamination. Small manufacturing residues can remain. The M-M-R II label lists no aluminum, thimerosal or formaldehyde; VAXELIS has a different ingredient list. Manufacturing cell cultures are not interchangeable with final ingredients. Check the actual product label.",
      "sources": [
        1,
        2,
        3
      ],
      "detailTopics": [],
      "sourceIds": [
        "vaccine-update-i1",
        "vaccine-update-i5",
        "vaccine-update-i6"
      ]
    },
    {
      "id": "aluminum",
      "heading": "Aluminum helps some vaccines work",
      "text": "A 2026 review of 59 studies found no established broad serious long-term harm from aluminum adjuvants, while recognizing uncommon persistent itchy nodules and local hypersensitivity. Evidence quality varied, and rare or delayed outcomes remain less certain. A 2022 US study reported an asthma association; the later Danish cohort did not reproduce an increased asthma association. Association alone does not establish cause.",
      "sources": [
        4,
        5,
        6
      ],
      "detailTopics": [
        "vaccines-autism"
      ],
      "quickLink": "Aluminum",
      "sourceIds": [
        "vaccine-update-i2",
        "vaccine-update-i3",
        "vaccine-update-a2"
      ]
    },
    {
      "id": "formaldehyde",
      "heading": "Small residues are assessed as injected doses",
      "text": "Some vaccines contain formaldehyde left over from manufacturing. Safety depends on the amount, route and how the body processes it. An infant model examining an injected dose found a small addition to the body’s existing formaldehyde burden. That supports the assessment; natural occurrence alone does not prove safety. This was a model, not a trial measuring every infant.",
      "sources": [
        1,
        7
      ],
      "detailTopics": [
        "newborn-hepatitis-b"
      ],
      "quickLink": "Formaldehyde",
      "sourceIds": [
        "vaccine-update-i1",
        "vaccine-update-i4"
      ]
    },
    {
      "id": "thimerosal",
      "heading": "Thimerosal is formulation-specific",
      "text": "Thimerosal is a preservative that contains ethylmercury, which differs from methylmercury. Some multidose flu products have contained it; many vaccines do not. Studies do not support an autism link. An approved label, a recommendation and what is locally available are separate facts.",
      "sources": [
        8,
        9
      ],
      "detailTopics": [],
      "quickLink": "Thimerosal",
      "sourceIds": [
        "vaccine-update-i8",
        "vaccine-update-a1"
      ]
    },
    {
      "id": "ingredient-safety",
      "heading": "Safety and side effects",
      "text": "Uncommon aluminum-related nodules can cause prolonged discomfort. Severe allergic reactions to a vaccine component are rare but real. The ingredient, product and person’s history matter. Neither “natural” nor a chemical’s alarming name settles the safety of a particular exposure.",
      "sources": [
        1,
        4
      ],
      "detailTopics": [
        "vaccine-schedule"
      ],
      "quickLink": "Safety and side effects",
      "sourceIds": [
        "vaccine-update-i1",
        "vaccine-update-i2"
      ]
    }
  ],
  "sources": [
    {
      "id": "vaccine-update-i1",
      "title": "Common Ingredients in FDA-Approved Vaccines",
      "publisher": "FDA",
      "url": "https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/common-ingredients-fda-approved-vaccines",
      "readerBlurb": "Ingredients serve different functions; safety assessment needs the product, amount and route of exposure.",
      "limit": "Ingredients serve different functions; safety assessment needs the product, amount and route of exposure.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Ingredients serve different functions; safety assessment needs the product, amount and route of exposure."
      },
      "publicationTitle": "Common Ingredients in FDA-Approved Vaccines",
      "archiveDate": "2026-10-14",
      "supports": [
        "Each ingredient has a job",
        "Small residues are assessed as injected doses",
        "Safety and side effects"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Ingredients serve different functions; safety assessment needs the product, amount and route of exposure."
      ],
      "limitationsPublic": [
        "Ingredients serve different functions; safety assessment needs the product, amount and route of exposure."
      ]
    },
    {
      "id": "vaccine-update-i5",
      "title": "M-M-R II — Prescribing Information",
      "publisher": "FDA",
      "url": "https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123789.pdf",
      "readerBlurb": "Ingredient and manufacturing information for this formulation, not every MMR product worldwide.",
      "limit": "Ingredient and manufacturing information for this formulation, not every MMR product worldwide.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Ingredient and manufacturing information for this formulation, not every MMR product worldwide."
      },
      "publicationTitle": "M-M-R II — Prescribing Information",
      "archiveDate": "2026-10-14",
      "supports": [
        "Each ingredient has a job"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Ingredient and manufacturing information for this formulation, not every MMR product worldwide."
      ],
      "limitationsPublic": [
        "Ingredient and manufacturing information for this formulation, not every MMR product worldwide."
      ]
    },
    {
      "id": "vaccine-update-i6",
      "title": "VAXELIS — Prescribing Information",
      "publisher": "FDA",
      "url": "https://www.fda.gov/media/119465/download",
      "readerBlurb": "Six-disease combination vaccine; ingredient amounts are product-specific.",
      "limit": "Six-disease combination vaccine; ingredient amounts are product-specific.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Six-disease combination vaccine; ingredient amounts are product-specific."
      },
      "publicationTitle": "VAXELIS — Prescribing Information",
      "archiveDate": "2026-10-14",
      "supports": [
        "Each ingredient has a job"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Six-disease combination vaccine; ingredient amounts are product-specific."
      ],
      "limitationsPublic": [
        "Six-disease combination vaccine; ingredient amounts are product-specific."
      ]
    },
    {
      "id": "vaccine-update-i2",
      "title": "Aluminium adjuvants in vaccines and potential health effects: systematic review",
      "publisher": "BMJ, 2026",
      "url": "https://www.bmj.com/content/393/bmj-2025-088921",
      "readerBlurb": "59 studies with uneven evidence quality. Recognizes uncommon persistent local reactions and gaps for rare or delayed outcomes.",
      "limit": "59 studies with uneven evidence quality. Recognizes uncommon persistent local reactions and gaps for rare or delayed outcomes.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "59 studies with uneven evidence quality. Recognizes uncommon persistent local reactions and gaps for rare or delayed outcomes."
      },
      "publicationTitle": "Aluminium adjuvants in vaccines and potential health effects: systematic review",
      "archiveDate": "2026-10-14",
      "supports": [
        "Aluminum helps some vaccines work",
        "Safety and side effects"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "59 studies with uneven evidence quality. Recognizes uncommon persistent local reactions and gaps for rare or delayed outcomes."
      ],
      "limitationsPublic": [
        "59 studies with uneven evidence quality. Recognizes uncommon persistent local reactions and gaps for rare or delayed outcomes."
      ]
    },
    {
      "id": "vaccine-update-i3",
      "title": "Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months",
      "publisher": "Academic Pediatrics, 2022",
      "url": "https://pubmed.ncbi.nlm.nih.gov/36180331/",
      "readerBlurb": "US observational association needing further study; residual confounding remains possible.",
      "limit": "US observational association needing further study; residual confounding remains possible.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "US observational association needing further study; residual confounding remains possible."
      },
      "publicationTitle": "Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months",
      "archiveDate": "2026-10-14",
      "supports": [
        "Aluminum helps some vaccines work"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "US observational association needing further study; residual confounding remains possible."
      ],
      "limitationsPublic": [
        "US observational association needing further study; residual confounding remains possible."
      ]
    },
    {
      "id": "vaccine-update-a2",
      "title": "Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood: A Nationwide Cohort Study",
      "publisher": "Annals of Internal Medicine, 2025",
      "url": "https://pubmed.ncbi.nlm.nih.gov/40658954/",
      "readerBlurb": "Danish observational cohort of 1,224,176 children. Its supplement was corrected; rare-outcome uncertainty remains.",
      "limit": "Danish observational cohort of 1,224,176 children. Its supplement was corrected; rare-outcome uncertainty remains.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Danish observational cohort of 1,224,176 children. Its supplement was corrected; rare-outcome uncertainty remains."
      },
      "publicationTitle": "Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood: A Nationwide Cohort Study",
      "archiveDate": "2026-10-14",
      "supports": [
        "Aluminum helps some vaccines work"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Danish observational cohort of 1,224,176 children. Its supplement was corrected; rare-outcome uncertainty remains."
      ],
      "limitationsPublic": [
        "Danish observational cohort of 1,224,176 children. Its supplement was corrected; rare-outcome uncertainty remains."
      ]
    },
    {
      "id": "vaccine-update-i4",
      "title": "Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines",
      "publisher": "Vaccine, 2013",
      "url": "https://pubmed.ncbi.nlm.nih.gov/23583892/",
      "readerBlurb": "Models an intramuscular dose in a two-month-old infant; not direct measurement in every vaccinated child.",
      "limit": "Models an intramuscular dose in a two-month-old infant; not direct measurement in every vaccinated child.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Models an intramuscular dose in a two-month-old infant; not direct measurement in every vaccinated child."
      },
      "publicationTitle": "Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines",
      "archiveDate": "2026-10-14",
      "supports": [
        "Small residues are assessed as injected doses"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Models an intramuscular dose in a two-month-old infant; not direct measurement in every vaccinated child."
      ],
      "limitationsPublic": [
        "Models an intramuscular dose in a two-month-old infant; not direct measurement in every vaccinated child."
      ]
    },
    {
      "id": "vaccine-update-i8",
      "title": "Thimerosal and Vaccines",
      "publisher": "FDA",
      "url": "https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/thimerosal-and-vaccines",
      "readerBlurb": "Distinguishes ethylmercury from methylmercury; labels and recommendations need separate checks.",
      "limit": "Distinguishes ethylmercury from methylmercury; labels and recommendations need separate checks.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Distinguishes ethylmercury from methylmercury; labels and recommendations need separate checks."
      },
      "publicationTitle": "Thimerosal and Vaccines",
      "archiveDate": "2026-10-14",
      "supports": [
        "Thimerosal is formulation-specific"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Distinguishes ethylmercury from methylmercury; labels and recommendations need separate checks."
      ],
      "limitationsPublic": [
        "Distinguishes ethylmercury from methylmercury; labels and recommendations need separate checks."
      ]
    },
    {
      "id": "vaccine-update-a1",
      "title": "Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism",
      "publisher": "WHO, 2025",
      "url": "https://www.who.int/news/item/11-12-2025-statement-gacvs-vaccines-autism",
      "readerBlurb": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects.",
      "limit": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects."
      },
      "publicationTitle": "Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism",
      "archiveDate": "2026-10-14",
      "supports": [
        "Thimerosal is formulation-specific"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects."
      ],
      "limitationsPublic": [
        "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects."
      ]
    }
  ],
  "dossier": "vaccine-narratives-ingredients-2026-10-14.md",
  "limits": [
    "The findings apply to the vaccines, populations and outcomes studied. Personal recommendations depend on your health and current local guidance."
  ],
  "scope": "",
  "takeaway": "Vaccine ingredients have specific jobs, such as strengthening protection or keeping the vaccine stable.",
  "contextTitle": "",
  "contextIntro": "",
  "detail": "",
  "revision": "vaccine-2026-10-15",
  "researchDate": "2026-10-14",
  "copyReviewedAt": "2026-10-15",
  "locale": "en",
  "topic": "Vaccines",
  "tag": "Vaccine ingredients",
  "assessment": "Source-grounded explanation · research draft",
  "geographicScope": {
    "kind": "global",
    "countryCodes": [],
    "jurisdictionCodes": [],
    "note": "Evidence and jurisdiction limits are stated beside the relevant claims."
  },
  "reviewNeeds": "Independent clinical/editorial approval remains pending; no personalized schedule.",
  "updateTriggers": "New studies, corrected sources, regulatory safety signals and changed local recommendations.",
  "readerCopyEdition": "vaccine-clarity-2026-10-15",
  "questions": [],
  "questionsHeading": "Find the answer you need",
  "headline": {
    "text": "Vaccine ingredients have a strong safety record",
    "revision": 1,
    "status": "draft",
    "sourceMessageId": null,
    "approvedAt": null,
    "authority": "15 October 2026 authorized vaccine implementation; source-mapped editorial brief. Agent review is not clinical or owner approval."
  },
  "language": "en",
  "jurisdiction": {
    "kind": "global",
    "countryCodes": [],
    "jurisdictionCodes": [],
    "note": "Evidence and jurisdiction limits are stated beside the relevant claims."
  },
  "claimScope": "",
  "research": {
    "dossierRef": "docs/research/vaccine-narratives-ingredients-2026-10-14.md",
    "reviewedAt": "2026-10-14",
    "reviewDue": "New studies, corrected sources, regulatory safety signals and changed local recommendations.",
    "contraryEvidenceConsidered": [],
    "status": "research draft; editorial/context review separate"
  },
  "status": "researched draft preview",
  "realWorldClaimReviewed": false,
  "clinicalEditorialApproved": false
}